Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 6—June 2004
Research

Antimicrobial Resistance Incidence and Risk Factors among Helicobacter pylori–Infected Persons, United States

William M. Duck*, Jeremy Sobel*, Janet M. Pruckler*, Qunsheng Song*, David L. Swerdlow*, Cindy R. Friedman*, Alana Sulka*, Balasubra Swaminathan*, Tom Taylor*, Mike Hoekstra*, Patricia M. Griffin*, Duane Smoot†, Rick Peek‡, DavidC. Metz§, Peter B. Bloom¶, Steven Goldschmid¶, Julie Parsonnet#, George Triadafilopoulos#, Guillermo I. Perez-Perez**, Nimish Vakil††, Peter Ernst‡‡, Steve Czinn§§, Donald Dunne§§, and Ben D. Gold*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Howard University Medical Center, Washington, DC, USA; ‡Vanderbilt University Medical Center, Nashville, Tennessee, USA; §University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA; ¶Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA; #Stanford University Medical Center, Palo Alto, California, USA; **New York University School of Medicine, New York, New York, USA; ††Sinai Samaritan Medical Center, Milwaukee, Wisconsin, USA; ‡‡University of Virginia, Charlottesville, Virginia, USA; §§University Hospitals of Cleveland, Cleveland, Ohio, USA; ¶¶Indiana University Medical Center, Indianapolis, Indiana, USA

Main Article

Table 3

Resistance of HARP H. pylori isolates by sitea

Location No. isolates Amoxicillin
 Tetracycline
 Clarithromycin
 Metronidazole
 Resistant to 1 agent
 Resistant to >1 agent
 Resistant to >1 agent
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Atlanta, GA
 37
 0
 0
 7 (19)
 5 (14)
 4 (11)
 4 (11)
 8
Nashville, TN
 45
 1 (2)
 0
 5 (11)
 5 (11)
 0 (24)
 0
 11 (22)
Galveston, TX
 10
 0
 0
 1 (10)
 3 (30)
 0 (40)
 0
 4 (24)
Philadelphia, PA
 41
 1 (2)
 0
 6 (15)
 15 (37)
 16 (39)
 3 (7)
 19 (40)
Washington, DC
 93
 1 (2)
 0
 15 (16)
 31 (33)
 35 (38)
 6 (7)
 41 (46)
Indianapolis, IN
 36
 0
 0
 3 (8)
 15 (42)
 18 (50)
 0
 18
 (50)
Detroit, MI
 18
 0
 0
 3 (17)
 4 (22)
 3 (17)
 2 (11)
 5 (28)
Cleveland, OH
 6
 0
 0
 0
 1 (17)
 1 (17)
 0
 1 (17)
Milwaukee, WI
 15
 0
 0
 2 (13)
 3 (20)
 3 (20)
 1 (7)
 4 (27)
Stanford, CA
 24
 0
 0
 1 (4)
 4 (17)
 3 (13)
 1 (4)
 4 (17)
New York, NY 22 0 0 2 (9) 1 (5) 3 (14) 0 3 (40)

aN = 347; HARP, Helicobacter pylori Antimicrobial Resistance Monitoring Project.

Main Article

Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external